Cellular & Regenerative Medicine
Precision Development and Bioprocessing Are Creating the Next Generation of Potent Cellular & Regenerative Medicine
OVERVIEW
Knowledge of the powerful functional T-cell drivers can give complex engineered immune cell therapies the edge they need
IsoPlexis technology detects the highly polyfunctional cell subsets, typically missed in bulk, that correlate to in vivo outcome in cellular and regenerative medicine. Isolating these differences helps researchers engineer the potency and durability needed throughout development & bioprocessing.
Featured Tech Note
Get the most out of your CAR-T bioprocessing with the CliniMACS Prodigy® & IsoPlexis
featured webinars & interviews
See how industry leaders and pioneers are revealing the true functional biology to accelerate research and medicine
Learn how single-cell functional proteomics is crucial in the informed design and development of the next generation of cell therapies
Leonardo Ferreira, PhD, Post Doctoral Scholar, University of California, San Francisco
Uncover strategies to improve T-cell function in the TME, and Polyfunctional Strength Index (PSI) concerning a range of TME immunotherapy challenges
Sruthi Ravindranathan, PhD, Post Doctoral Researcher, Waller Lab, Winship Cancer Institute of Emory University
Discover the evolution of the cell therapy industry and how IsoPlexis is redefining what's possible through the ability to stratify patient response to novel immunotherapy regimens
James R. Heath, PhD, Professor and President of Institute of System Biology, Seattle
Publications & News
Publications highlight customer breakthroughs across research and medicine
Publications
Case Studies & Resources
Stay at the cutting edge of science and medicine with case studies, literature and resources
